{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:13:18Z","timestamp":1792811598158,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jtha.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T19:09:19Z","timestamp":1689620959000},"page":"2045-2047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coagulopathy of liver disease\u2014a pathophysiologic rebalance of hemostasis and thrombosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Alvin H.","family":"Schmaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.05.006_bib1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2015-06-650226","article-title":"A\u00a0first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects","volume":"127","author":"Uchida","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.05.006_bib2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(23)00284-2","article-title":"Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial","volume":"401","author":"Young","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.05.006_bib3","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/bloodadvances.2021006403","article-title":"Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors","volume":"6","author":"Shapiro","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.05.006_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman","year":"2007","journal-title":"Dig Surg"},{"key":"10.1016\/j.jtha.2023.05.006_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.05.006_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.05.006_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.05.006_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2022.05.004","article-title":"Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis","volume":"215","author":"Subhani","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.05.006_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1172\/JCI108773","article-title":"Dysfibrinogenemia associated with liver disease","volume":"60","author":"Palascak","year":"1977","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.05.006_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1172\/JCI108964","article-title":"Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease","volume":"61","author":"Martinez","year":"1978","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.05.006_bib11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jtha.2023.03.017","article-title":"In\u00a0vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation","volume":"21","author":"Elvers","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.05.006_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjh.12462","article-title":"Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels","volume":"162","author":"Potze","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362300418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362300418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:22Z","timestamp":1761536242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362300418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S153878362300418X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.05.006","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulopathy of liver disease\u2014a pathophysiologic rebalance of hemostasis and thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}